First Time Loading...

Medica Group PLC
LSE:MGP

Watchlist Manager
Medica Group PLC Logo
Medica Group PLC
LSE:MGP
Watchlist
Price: 211 GBX
Updated: May 6, 2024
Section:
 

Relative Value

The Relative Value of one MGP stock under the Base Case scenario is 295.53 GBX. Compared to the current market price of 211 GBX, Medica Group PLC is Undervalued by 29%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

MGP Relative Value
Base Case
295.53 GBX
Undervaluation 29%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

3.4
P/S
P/S
Price to Sales
3.4
vs History
34
vs Industry
37
Median 3Y
3.4
Median 5Y
3.4
Industry
2.4
Forward
2.9
More Details
35.9
P/E
P/E
Price to Earnings
35.9
vs History
22
vs Industry
15
Median 3Y
35.9
Median 5Y
29.9
Industry
23.4
Forward
19.3
More Details
29.5
P/OCF
P/OCF
Price to OCF
29.5
vs History
11
vs Industry
13
Median 3Y
29.4
Median 5Y
19.4
Industry
15.5
More Details
27.1
P/FCFE
P/FCFE
Price to FCFE
27.1
vs History
28
vs Industry
20
Median 3Y
27.1
Median 5Y
26.6
Industry
23.2
More Details
4.2
P/B
P/B
Price to Book Value
4.2
vs History
19
vs Industry
21
Median 3Y
3.6
Median 5Y
3.8
Industry
2.3
More Details
3.3
EV/S
EV/S
Enterprise Value to Sales
3.3
vs History
31
vs Industry
35
Median 3Y
3.3
Median 5Y
3.3
Industry
2.5
Forward
2.9
More Details
6.8
EV/GP
EV/GP
Enterprise Value to Gross Profit
6.8
vs History
33
vs Industry
34
Median 3Y
6.8
Median 5Y
6.8
Industry
5.3
More Details
17.9
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
17.9
vs History
19
vs Industry
20
Median 3Y
17.9
Median 5Y
13.3
Industry
12.6
Forward
13.3
More Details
27.3
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
27.3
vs History
20
vs Industry
17
Median 3Y
27.3
Median 5Y
19.8
Industry
17.2
Forward
15.2
More Details
29
EV/OCF
EV/OCF
Enterprise Value to OCF
29
vs History
11
vs Industry
14
Median 3Y
28.9
Median 5Y
18.7
Industry
15.3
More Details
43.5
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
43.5
vs History
11
vs Industry
12
Median 3Y
43.3
Median 5Y
25.1
Industry
19.8
More Details
3.9
EV/IC
EV/IC
Enterprise Value to IC
3.9
vs History
30
vs Industry
23
Median 3Y
3.1
Median 5Y
3.9
Industry
2
More Details

Multiples Across Competitors

MGP Competitors Multiples
Medica Group PLC Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
UK
Medica Group PLC
LSE:MGP
258.3m GBP 3.4 35.9 17.9 27.3
US
Cigna Group
XMUN:CGN
93.5B EUR 0.5 19.5 10 13.4
US
Cigna Corp
NYSE:CI
99.9B USD 0.5 19.3 10 13.3
US
CVS Health Corp
NYSE:CVS
70B USD 0.2 9.6 8.7 8.7
US
Laboratory Corporation of America Holdings
NYSE:LH
17B USD 1.4 39.2 11.9 18
DE
Fresenius SE & Co KGaA
XETRA:FRE
15.7B EUR 0.7 -26.5 10.1 22.6
US
Quest Diagnostics Inc
NYSE:DGX
15.2B USD 1.6 18.1 10.8 14.6
DE
Fresenius Medical Care AG
XMUN:FME
11.9B EUR 0.6 23.9 7 16.6
DE
Fresenius Medical Care AG & Co KGaA
XETRA:FME
11.6B EUR 0.6 23.3 6.9 16.4
US
DaVita Inc
NYSE:DVA
11.9B USD 1 17.3 8.4 12.4
US
Oak Street Health Inc
NYSE:OSH
9.5B USD 4.4 -18.6 -23.3 -21.5

See Also

Summary
MGP intrinsic value, competitors valuation, and company profile.
DCF Valuation
MGP stock valuation using Discount Cash Flow valuation method.
Relative Valuation
MGP stock valuation using valuation multiples.
Wall Street Estimates
MGP price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
MGP stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 134,600+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.